Cargando…

Chronic Kidney Disease Associated with Worsening White Matter Disease and Ventricular Enlargement

BACKGROUND: Chronic kidney disease (CKD), a growing public health issue in the elderly, is associated with increased risk of cognitive impairment. OBJECTIVE: To investigate the mechanisms through which CKD impacts brain health using longitudinal imaging. METHODS: We identified 97 participants (74 CK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vemuri, Prashanthi, Davey, Cynthia, Johansen, Kirsten L., Zuk, Samantha M., Reid, Robert I., Thostenson, Kaely B., Reddy, Ashritha L., Jack, Clifford R., Knopman, David S., Murray, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609691/ https://www.ncbi.nlm.nih.gov/pubmed/34459402 http://dx.doi.org/10.3233/JAD-210604

Ejemplares similares

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Role of structural MRI in Alzheimer's disease
por: Vemuri, Prashanthi, et al.
Publicado: (2010)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Resting state functional MRI in Alzheimer's Disease
por: Vemuri, Prashanthi, et al.
Publicado: (2012)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Cascading network failure across the Alzheimer’s disease spectrum
por: Jones, David T., et al.
Publicado: (2016)

Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Investigation of white matter PiB uptake as a marker of white matter integrity
por: Zeydan, Burcu, et al.
Publicado: (2019)

Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities
por: Shen, Xinpeng, et al.
Publicado: (2022)

Diagnostic neuroimaging across diseases
por: Klöppel, Stefan, et al.
Publicado: (2011)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2021)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

White’s Operation for Enlarged Prostate
por: Haynes, Francis L.
Publicado: (1894)

“Exceptional brain aging” without Alzheimer’s disease: triggers, accelerators, and the net sum game
por: Vemuri, Prashanthi
Publicado: (2018)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

Study of Symptomatic vs. Silent Brain Infarctions on MRI in Elderly Subjects
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Improved DTI registration allows voxel-based analysis that outperforms Tract-Based Spatial Statistics
por: Schwarz, Christopher G., et al.
Publicado: (2014)

Lecanemab reduces brain amyloid-β and delays cognitive worsening
por: Knopman, David S.
Publicado: (2023)

Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
por: Nguyen, Aivi T., et al.
Publicado: (2022)

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
por: Vemuri, Prashanthi, et al.
Publicado: (2011)

A face-off of MRI research sequences by their need for de-facing
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
por: Ramanan, Vijay K, et al.
Publicado: (2019)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Pathophysiology of Greedy Colon and Diabetes: Role of Atropine in worsening of Diabetes
por: Gundamaraju, Rohit, et al.
Publicado: (2014)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods
por: Gunter, Nathaniel B., et al.
Publicado: (2018)

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors
por: Raman, Mekala R., et al.
Publicado: (2016)

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
por: Pink, Anna, et al.
Publicado: (2023)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease
por: Jack, Clifford R., et al.
Publicado: (2010)

Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
por: Mielke, Michelle M, et al.
Publicado: (2014)

Estimated GFR, Albuminuria, and Physical Function: The Brain in Kidney Disease (BRINK) Cohort Study
por: Mello, Ryan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1t1c5b84a24dv7721o3op7onl